Final Analysis of PEARL Study Evaluates Durvalumab Versus Chemotherapy as First-Line Treatment for NSCLC
Are In-person Evaluations Necessary for Remote Monitored Patients With Cardiovascular Implantable Electronic Devices?
Amusement Park Rides Appear Safe for People With Cardiac Devices